COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIA

This publication has 24 references indexed in Scilit:

• RENAL FAILURE ASSOCIATED WITH INTRAVENOUS DIPHOSPHONATES
  The Lancet, 1983
• Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calcium
  Calcified Tissue International, 1982
• Comparison of two parenteral diphosphonates in hypercalcemia of malignancy
  The American Journal of Medicine, 1982
• Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
  Journal of Clinical Investigation, 1980
• INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)
  The Lancet, 1979
• Effect of mithramycin therapy on strontium and calcium metabolism in cancer patients (A preliminary report)
  Journal of Surgical Oncology, 1972
• New approach to the treatment of hypercalcemia The effect of short‐term treatment with mithramycin
  Clinical Pharmacology & Therapeutics, 1971
• Mithramycin treatment of hypercalcemia
  Cancer, 1970
• Precipitous Fall in Serum Calcium, Hypotension, and Acute Renal Failure After Intravenous Phosphate Therapy for Hypercalcemia
  Annals of Internal Medicine, 1967
• A specific method for the analysis of hydroxyproline in tissues and urine
  Analytical Biochemistry, 1960